2 research outputs found

    The use of sesame oil in sea bream feeds and its effects on growth and body chemical composition

    Get PDF
    As fish oil availability declines worldwide and its price rises, there is a growing need to engage in scientific investigations into alternative oil sources for incorporation into fish feeds. This study aimed to determine the effects of dietary sesame oil on the growth performance, feed utilization, and nutritional composition of sea bream (*Sparus aurata*). Twenty-five individual fish (initial mean weight: 32.38±0.27 g) were placed in each tank in triplicate. Four experimental fish meal-based (iso-proteic 49% and iso-lipidic 20%) diets were formulated; the control (C) group contains 100% of fish oil (FO) and varying amounts (20, 40, 60%) of sesame oil (SO). During the 75-day experiment, the fish were fed 3 times a day, and the mean ambient temperature and dissolved oxygen values were measured as 22.5±0.5°C and 6.8±0.3 mg/L, respectively. At the beginning of the experiment, 20 fish were sampled to determine their nutrient composition and somatic indexes. In the end, 4 fish were collected for the same procedures and 4 for each tank's muscle and liver fatty acid compositions. At the end of the study, the S60 group exhibited the lowest final weight (FW) and feed utilization parameters. On the other hand, there were no statistical differences between FO, SO20, and SO40 in terms of FW. In addition, the SO40 group had the best feed conversion ratio (FCR) among the groups (P\<0.05). The whole-body lipid compositions of the groups were different. The highest lipid level was found in SO40 with 15.83±0.36%. Muscle and liver fatty acid composition was significantly affected by the fatty acid profile of experimental feeds. While total ω-6 fatty acids were higher in the SO groups than in group C, total ω-3 fatty acids were higher in the C group compared to the SO groups (P\<0.05). The ω-3/ω-6 ratios in the SO20 and SO40 groups showed similarity, while the highest ratio was observed in the control group (P\<0.05). As a result, according to data obtained from our study, it is predicted that 40% SO could be added to sea bream feed instead of FO in terms of growth performance, feed utilization, and nutritional composition

    The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients.

    No full text
    Objectives: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Study design: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. Results: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Conclusion: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients. © 2011 Turkish Society of Cardiology
    corecore